chr8-80177631-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000519250.5(TPD52):n.235+40838T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.219 in 152,428 control chromosomes in the GnomAD database, including 6,517 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.22 ( 6517 hom., cov: 33)
Exomes 𝑓: 0.023 ( 0 hom. )
Consequence
TPD52
ENST00000519250.5 intron
ENST00000519250.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.74
Genes affected
TPD52 (HGNC:12005): (tumor protein D52) Enables calcium ion binding activity and protein homodimerization activity. Involved in B cell differentiation. Located in endoplasmic reticulum and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.522 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LOC105375920 | XR_929095.3 | n.*23T>C | downstream_gene_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.219 AC: 33294AN: 152134Hom.: 6502 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
33294
AN:
152134
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0227 AC: 4AN: 176Hom.: 0 Cov.: 0 AF XY: 0.0319 AC XY: 3AN XY: 94 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
4
AN:
176
Hom.:
Cov.:
0
AF XY:
AC XY:
3
AN XY:
94
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
1
AN:
2
American (AMR)
AF:
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
AC:
0
AN:
2
European-Finnish (FIN)
AF:
AC:
0
AN:
2
Middle Eastern (MID)
AF:
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
AC:
3
AN:
162
Other (OTH)
AF:
AC:
0
AN:
4
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000005), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.219 AC: 33359AN: 152252Hom.: 6517 Cov.: 33 AF XY: 0.219 AC XY: 16297AN XY: 74440 show subpopulations
GnomAD4 genome
AF:
AC:
33359
AN:
152252
Hom.:
Cov.:
33
AF XY:
AC XY:
16297
AN XY:
74440
show subpopulations
African (AFR)
AF:
AC:
21895
AN:
41510
American (AMR)
AF:
AC:
2594
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
462
AN:
3468
East Asian (EAS)
AF:
AC:
287
AN:
5182
South Asian (SAS)
AF:
AC:
1068
AN:
4822
European-Finnish (FIN)
AF:
AC:
1024
AN:
10618
Middle Eastern (MID)
AF:
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5517
AN:
68028
Other (OTH)
AF:
AC:
410
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1082
2164
3245
4327
5409
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
562
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
Loading publications...